Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
European Commission
Pharma
European officials approve Novo Holdings' planned Catalent buy
Novo Holdings’ proposed $16.5 billion buyout of CDMO giant Catalent has received a major vote of confidence from antitrust officials overseas.
Fraiser Kansteiner
Dec 6, 2024 2:48pm
EU authorities revoke marketing nod for Advanz Pharma's Ocaliva
Dec 2, 2024 2:54pm
Teva hit with €463M fine over Copaxone misconduct claims in EU
Oct 31, 2024 10:45am
Swiss antitrust regulator drops investigation against Novartis
Oct 10, 2024 9:46am
Apellis hit with yet another eye drug snub in Europe
Sep 20, 2024 10:06am
EU signs off on Regeneron's T-cell engager for 2 blood cancers
Aug 26, 2024 10:35am
